Cell Nucleus News and Research

RSS

Dolutegravir drug offers added benefit in HIV patients

Dolutegravir has been approved since January 2014 in combination with other antiretroviral drugs for the treatment of human immunodeficiency virus (HIV) infected adults and adolescents above 12 years of age.

22 May 2014

Circadian disruption during chemotherapy linked to greater fatigue and body weight loss, says study

The circadian system, better known as our biological clock, is responsible for coordinating all the processes that take place in our organism.

21 May 2014

DNA-directed RNA interference and hepatitis C: an interview with Carl Stubbings, Chief Business Officer, Benitec Biopharma

RNA interference (RNAi) is a naturally occurring process, which cells can use to silence, or ‘turn off’ unwanted genes.

From Quest Diagnostics 19 May 2014

St. Jude analysis reveals how protein p53 triggers cancer cells to commit suicide

St. Jude Children's Research Hospital scientists have mapped the structural details of how p53 attaches to its regulatory protein, called BCL-xL, in the cell.

16 May 2014

Shark antibodies reveal evolutionary principles of immunoglobulins

Custom-tailored antibodies are regarded as promising weapons against a multitude of serious illnesses. Since they can accurately recognize specific structures on the surface of viruses, bacteria or cancer cells, they are already being deployed successfully in cancer diagnostics and therapy, as well as against numerous other diseases. The stability of the sensitive antibodies is a decisive factor in every step, from production and storage to therapeutic application.

15 May 2014

Researchers identify certain neurons responsible for behavioral decisions in rats

A new paper published by OIST's Neurobiology Research Unit identifies some of the neurons responsible for behavioral decisions in rats. Using a technique that employs light to control nerve cell activity, researchers in Professor Jeff Wickens' Unit inactivated a region of the brain and showed that it caused the rats to behave more flexibly while trying to get a reward.

15 May 2014

UofL institute and physician-director receive 2 MediStar awards

An institute at the University of Louisville and the physician-director of UofL's James Graham Brown Cancer Center won two MediStar awards presented May 13 at the Hyatt Regency Louisville.

15 May 2014

Researchers develop new high-tech device for transferring DNA into cells

The ability to transfer a gene or DNA sequence from one animal into the genome of another plays a critical role in a wide range of medical research-including cancer, Alzheimer's disease, and diabetes.

14 May 2014

Scientists find protein that controls DNA organization during sperm development

Infertility is generally thought of as a woman's problem. In fact, more than 3 million men across America also experience it.

13 May 2014

Researchers identify new molecular circuit that controls longevity in yeast and complex organisms

Ancient philosophers looked to alchemy for clues to life everlasting. Today, researchers look to their yeast.

9 May 2014

FABP5 protein enhances cognitive function

Case Western Reserve researchers have discovered that a protein previously implicated in disease plays such a positive role in learning and memory that it may someday contribute to cures of cognitive impairments.

5 May 2014

Researchers create tiny, biodegradable nanoparticles that carry DNA to brain cancer cells

Working together, Johns Hopkins biomedical engineers and neurosurgeons report that they have created tiny, biodegradable “nanoparticles” able to carry DNA to brain cancer cells in mice.

30 Apr 2014

Virginia Tech scientist receives grant to develop technique to detect subcellular location of protein

Virginia Tech chemical engineer Chang Lu and his colleagues have used a National Science Foundation grant to develop a technique to detect subcellular location of a protein.

26 Apr 2014

Johns Hopkins research may help manage the disruptive effects experienced by shift workers

Johns Hopkins researchers report that they have identified a protein essential to the formation of the tiny brain region in mice that coordinates sleep-wake cycles and other so-called circadian rhythms.

26 Apr 2014

Study finds role of oligomers in development of Parkinson's disease

Researchers at Aarhus University, Denmark, have drawn up the most detailed 'image of the enemy' to date of one of the body's most important players in the development of Parkinson's disease.

26 Apr 2014

Study reveals how human genome is protected from inadvertent import of viral RNA into cell

Scientists of the Max F. Perutz Laboratories of the University of Vienna and the Medical University of Vienna, together with colleagues of the ETH Zurich, have now shown how double stranded RNA, such as viral genetic information, is prevented from entering the nucleus of a cell.

23 Apr 2014

Study explains biological processes of malignant cancer cells

Cancer cells may be known for their uncontrollable growth and spread, but they also differ from normal tissue in another manner: how they produce energy.

22 Apr 2014

FDA approves Cochlear's Aqua+ accessory for cochlear implant recipients

Cochlear Limited, the global leader in implantable hearing solutions, announced that the US Food and Drug Administration has approved the Aqua+ accessory, the only waterproof behind-the-ear solution for cochlear implant recipients on the market today.

21 Apr 2014

Study sheds light on how extra chromosome 21 upsets equilibrium of entire genome in Down syndrome

Occurring in about one per eight hundred births, Down syndrome - or trisomy 21 - is the most frequent genetic cause of intellectual disability. It results from a chromosomal abnormality where cells of affected individuals contain a third copy of chromosome 21 (1% of the human genome).

18 Apr 2014

Engineering cell-based, biological devices may selectively kill cancer cells without disrupting healthy cells

A Northwestern University synthetic biology team has created a new technology for modifying human cells to create programmable therapeutics that could travel the body and selectively target cancer and other sites of disease.

18 Apr 2014

Cell Nucleus News and Research

Dolutegravir drug offers added benefit in HIV patients

Circadian disruption during chemotherapy linked to greater fatigue and body weight loss, says study

DNA-directed RNA interference and hepatitis C: an interview with Carl Stubbings, Chief Business Officer, Benitec Biopharma

St. Jude analysis reveals how protein p53 triggers cancer cells to commit suicide

Shark antibodies reveal evolutionary principles of immunoglobulins

Researchers identify certain neurons responsible for behavioral decisions in rats

UofL institute and physician-director receive 2 MediStar awards

Researchers develop new high-tech device for transferring DNA into cells

Scientists find protein that controls DNA organization during sperm development

Researchers identify new molecular circuit that controls longevity in yeast and complex organisms

FABP5 protein enhances cognitive function

Researchers create tiny, biodegradable nanoparticles that carry DNA to brain cancer cells

Virginia Tech scientist receives grant to develop technique to detect subcellular location of protein

Johns Hopkins research may help manage the disruptive effects experienced by shift workers

Study finds role of oligomers in development of Parkinson's disease

Study reveals how human genome is protected from inadvertent import of viral RNA into cell

Study explains biological processes of malignant cancer cells

FDA approves Cochlear's Aqua+ accessory for cochlear implant recipients

Study sheds light on how extra chromosome 21 upsets equilibrium of entire genome in Down syndrome

Engineering cell-based, biological devices may selectively kill cancer cells without disrupting healthy cells

Event Guide: 3rd Annual TRP Supply Chain & Manufacturing Summit eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News